ArticleThe oncologist2024

A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX.

Jacob K Jamison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.